Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms 124I-CPD-1028, 125I-CPD-1028, CPD-1028-[124I] + [2] |
Target |
Mechanism IGF-1R modulators(Insulin-like growth factor I receptor modulators), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | CA | 01 Jun 2014 |